• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于导管的冠状动脉疾病治疗:过去、现在和未来。

Catheter-based treatment of coronary artery disease: past, present, and future.

机构信息

Mayo Clinic, Rochester, MN 55901, USA.

出版信息

Circ Cardiovasc Interv. 2008 Aug;1(1):60-73. doi: 10.1161/CIRCINTERVENTIONS.108.783134.

DOI:10.1161/CIRCINTERVENTIONS.108.783134
PMID:20031656
Abstract

September 2007 marked the 30-year anniversary of the first human percutaneous coronary intervention, an index event that changed the course of modern-day cardiovascular care. Before that first procedure, adult invasive cardiology focused on diagnostic angiography as well as hemodynamic assessment of structural heart disease. Since that initial procedure, percutaneous coronary intervention has become the most frequently performed coronary revascularization procedure worldwide. Several factors have been responsible for this dramatic paradigm shift, the most prominent being identification of opportunities for technical improvement and the application of innovation and investigation in concert with colleagues, professional societies, and industry. These approaches will continue to be of paramount importance as new technologies are brought to bear on an increasingly broader group of patients with cardiovascular disease.

摘要

2007 年 9 月标志着首例人类经皮冠状动脉介入治疗的 30 周年,这一里程碑事件改变了现代心血管护理的进程。在此之前,成人介入心脏病学主要专注于诊断性血管造影以及结构性心脏病的血流动力学评估。自首例手术以来,经皮冠状动脉介入治疗已成为全球最常施行的冠状动脉血运重建术。有几个因素促成了这一戏剧性的范式转变,其中最突出的是确定了技术改进的机会,并与同事、专业协会和行业一起应用创新和研究。随着新技术应用于越来越广泛的心血管疾病患者群体,这些方法仍将至关重要。

相似文献

1
Catheter-based treatment of coronary artery disease: past, present, and future.基于导管的冠状动脉疾病治疗:过去、现在和未来。
Circ Cardiovasc Interv. 2008 Aug;1(1):60-73. doi: 10.1161/CIRCINTERVENTIONS.108.783134.
2
API expert consensus document on management of ischemic heart disease.缺血性心脏病管理的API专家共识文件
J Assoc Physicians India. 2006 Jun;54:469-80.
3
Recent progress in percutaneous coronary intervention: evolution of the drug-eluting stents, focus on the XIENCE V drug-eluting stent.经皮冠状动脉介入治疗的最新进展:药物洗脱支架的演变,聚焦于XIENCE V药物洗脱支架。
Coron Artery Dis. 2010 Jan;21(1):46-56. doi: 10.1097/MCA.0b013e328333f550.
4
Myocardial revascularization by percutaneous coronary intervention: past, present, and the future.经皮冠状动脉介入治疗的心肌血运重建:过去、现在和未来。
Curr Probl Cardiol. 2011 Oct;36(10):375-401. doi: 10.1016/j.cpcardiol.2011.05.005.
5
Management and outcome of patients with established coronary artery disease: the Euro Heart Survey on coronary revascularization.已确诊冠心病患者的管理与预后:欧洲冠状动脉血运重建调查
Eur Heart J. 2005 Jun;26(12):1169-79. doi: 10.1093/eurheartj/ehi238. Epub 2005 Mar 31.
6
One-year clinical results and total costs of drug-eluting stents implantation in multivessel coronary artery disease.药物洗脱支架植入治疗多支冠状动脉疾病的一年临床结果及总成本
J Cardiovasc Med (Hagerstown). 2007 Aug;8(8):596-601. doi: 10.2459/JCM.0b013e32801051f4.
7
Multivessel percutaneous coronary intervention: a new paradigm for a new century.多支血管经皮冠状动脉介入治疗:新世纪的新范例。
Minerva Cardioangiol. 2005 Oct;53(5):361-77.
8
Multivessel disease: percutaneous coronary intervention for classic coronary artery bypass grafting indications.多支血管病变:用于经典冠状动脉旁路移植术适应症的经皮冠状动脉介入治疗
Angiology. 2008 Apr-May;59(2 Suppl):83S-8S. doi: 10.1177/0003319708318862. Epub 2008 Jun 10.
9
Multivessel coronary drug-eluting stenting alone in patients with significant ischemic mitral regurgitation: a 4-year follow up.仅对存在严重缺血性二尖瓣反流的患者进行多支冠状动脉药物洗脱支架置入术:4年随访
J Invasive Cardiol. 2008 Jan;20(1):41-3.
10
Coronary artery bypass surgery versus percutaneous coronary artery intervention in patients on chronic hemodialysis: does a drug-eluting stent have an impact on clinical outcome?慢性血液透析患者的冠状动脉搭桥手术与经皮冠状动脉介入治疗:药物洗脱支架对临床结局有影响吗?
J Card Surg. 2009 May-Jun;24(3):234-9. doi: 10.1111/j.1540-8191.2008.00789.x.

引用本文的文献

1
Hardware Failure as a Rare Complication of Percutaneous Coronary Intervention: A Case Report.硬件故障作为经皮冠状动脉介入治疗的罕见并发症:一例报告
J Tehran Heart Cent. 2021 Oct;16(4):169-173. doi: 10.18502/jthc.v16i4.8603.
2
Utility of adjunctive modalities in Coronary chronic total occlusion intervention.辅助手段在冠状动脉慢性完全闭塞病变介入治疗中的应用价值
Indian Heart J. 2017 May-Jun;69(3):375-381. doi: 10.1016/j.ihj.2017.02.015. Epub 2017 Feb 24.
3
Factors Associated with Early Adverse Events after Coronary Artery Bypass Grafting Subsequent to Percutaneous Coronary Intervention.
经皮冠状动脉介入治疗后冠状动脉旁路移植术后早期不良事件的相关因素。
Korean J Thorac Cardiovasc Surg. 2016 Jun;49(3):171-6. doi: 10.5090/kjtcs.2016.49.3.171. Epub 2016 Jun 5.
4
Vascular access and closure in coronary angiography and percutaneous intervention.冠状动脉造影和介入治疗中的血管通路和闭合。
Nat Rev Cardiol. 2013 Jan;10(1):27-40. doi: 10.1038/nrcardio.2012.160. Epub 2012 Nov 27.
5
Twenty-year evolution of percutaneous coronary intervention and its impact on clinical outcomes: a report from the National Heart, Lung, and Blood Institute-sponsored, multicenter 1985-1986 PTCA and 1997-2006 Dynamic Registries.经国家心肺血液研究所资助的多中心 1985-1986 年经皮冠状动脉介入治疗和 1997-2006 年动态登记研究二十年演变及其对临床结果的影响。
Circ Cardiovasc Interv. 2009 Feb;2(1):6-13. doi: 10.1161/CIRCINTERVENTIONS.108.825323. Epub 2008 Dec 15.
6
CT coronary angiography of chronic total occlusions of the coronary arteries: how to recognize and evaluate and usefulness for planning percutaneous coronary interventions.冠状动脉慢性完全闭塞病变的CT冠状动脉造影:如何识别、评估以及对经皮冠状动脉介入治疗规划的有用性
Int J Cardiovasc Imaging. 2009 Apr;25 Suppl 1:43-54. doi: 10.1007/s10554-009-9424-7. Epub 2009 Jan 23.